10.1038/ncomms1681 - miR-196b directly targets both HOXA9/...

This document has been corrected

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

10.1038/ncomms1681

Published Online: 2012-02-21

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Abdel Elkahloun•Bob Lowenberg•Chen Shen•Chunjiang He•Donglin Cao•Elizabeth Hyjek•Hao Huang•James C. Mulloy•James Vardiman•Jianjun Chen•Jie Jin•Jiwang Zhang•Jun Lu•Jun Zhang•Mark Wunderlich•Mary Beth Neilly•Miao He•Michelle M. Le Beau•Minjie Wei•Nancy J. Zeleznik-Le•Paul P. Liu•Peter J.M. Valk•Ping Chen•Ruud Delwel•Stephen Arnovitz•Xi Jiang•Yuanyuan Li•Yungui Wang•Zejuan Li•Zhiyu Zhang

This document has been corrected

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

10.1038/ncomms1681

Published Online: 2012-02-21

Journal: Nature Communications

NOW

2018-04-10•Correction

Correction: Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

10.1038/ncomms16192

* information provided by CrossRef

2018-04-10•Correction

10.1038/ncomms16192

* information provided by CrossRef

2012-02-21•Published

2018-04-10•Correction

Correction: Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

10.1038/ncomms16192

* information provided by CrossRef

This document has been corrected

miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia

10.1038/ncomms1681

Published Online: 2012-02-21

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC